FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Townsend Christopher G 		2. Issuer Name and Ticker or Trading Symbol

METLIFE INC [ MET ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President, Asia
(Last)          (First)          (Middle)

LEVEL 20, CITYPLAZA 3, 14 TAIKOO WAN ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

11/6/2017
(Street)

TAIKOO SHING, K3 00000
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   11/6/2017     M    25181   A $45.15   25181   D    
Common Stock   11/6/2017     S    25181   D $54.343   (1) (2) 0   D    
Common Stock   11/6/2017     M    17425   A $45.91   17425   D    
Common Stock   11/6/2017     S    17425   D $54.289   (1) (3) 0   D    
Common Stock   11/6/2017     M    13106   A $34.33   13106   D    
Common Stock   11/6/2017     S    13106   D $54.20   (1) (4) 0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $45.15   11/6/2017     M         25181      (5) 2/24/2024   Common Stock   25181   $0.00   0   D    
Employee Stock Option (Right to Buy)   $45.91   11/6/2017     M         17425      (6) 2/23/2025   Common Stock   17425   $0.00   8713   D    
Employee Stock Option (Right to Buy)   $34.33   11/6/2017     M         13106      (7) 2/22/2026   Common Stock   13106   $0.00   26216   D    

Explanation of Responses:
(1)  The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.
(2)  The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive.
(3)  The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive.
(4)  The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive.
(5)  The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017.
(6)  The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018.
(7)  The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Townsend Christopher G
LEVEL 20, CITYPLAZA 3
14 TAIKOO WAN ROAD
TAIKOO SHING, K3 00000

President, Asia

Signatures
Mark A. Schuman, authorized signer 11/8/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
MetLife (NYSE:MET)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more MetLife Charts.
MetLife (NYSE:MET)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more MetLife Charts.